Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03227016
Title Study in Patients With SCLC of Veliparib in Combination With Topotecan
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Central European Society for Anticancer Drug Research
Indications

lung small cell carcinoma

Therapies

Topotecan + Veliparib

Age Groups: adult | senior
Covered Countries DEU

Facility Status City State Zip Country Details
Klinik München Gauting Recruiting München Gauting Germany Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field